The present study was conducted to assess the effects of chronic treatment with triiodothyronine (T3) on mRNA expression of uncoupling protein (UCP) family in male Wistar King A rats. Subcutaneous injection of T3 (37 nmolabody weight 100 g) over 7 d increased mRNA expression of UCP1 in brown adipose tissue (BAT), UCP2 in white adipose tissue (WAT), and UCP3 in skeletal muscle (MSL) mRNA by 1.3, 1.7, and 2.0-fold, respectively. In contrast, the expression of ob gene mRNA in WAT and serum leptin level in the T3-treated rats decreased by 0.5-fold of the controls. These results suggest that T3 may increase UCP family expression independent of leptin action.
Introduction
While oxidation of fuels generates a proton electrochemical gradient across the inner mitochondrial membrane and re-entry of these protons via ATP synthetase drives conversion of ADP to ATP, uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which dissipate the proton gradient by releasing stored energy as heat. Therefore, UCPs are potentially important determinants of metabolic ef®ciency in mammals. 1 Thyroid hormone has been shown to play an important role in to function of UCP1 in cold exposure. brown adipose tissue (BAT) UCP1 is a major thermogenic organ in rodents; however it may be of lesser importance in adult humans in whom the mass of brown adipose tissue is limited. Some alternative modulator has been needed in humans as an adaptive thermogenesis for maintenance of homeostatic energy expenditure. UCP2 and UCP3 are recently cloned homologues of UCP1 2,3 and could be involved in the regulation of energy balance. UCP2 and UCP3 are respectively expressed at ubiquitous organs and MSL both in humans and rodents 2, 3 unlike the unique expression of UCP1 in BAT.
The present study was aimed at examining whether the novel UCPs may play essential roles in energy expenditure of hyperthyroid rats. In addition, mRNA expressions of ob gene and serum leptin concentration were measured to clarify an interactive effect between treatment with triiodothyronine (T3) and ob gene expression on mRNA levels of the UCP family.
Material and methods

Rat treatment
Mature male Wistar King A (WKA) rats (Seac Yoshitomi Ltd, Fukuoka, Japan), at 8 ± 10 week of age were used. Matched on the basis of body weight on the ®rst injection day, 8 rats were equally divided into T3-treated and saline-treated. Rats were injected daily with a subcutaneous injection of T3 (triiodothyronine, Aldrich Chemical Co., Milwaukee, USA) at the dose of 37 nmolabody weight 100 ga0.1 ml for 7 d. Control rats were also injected daily with subcutaneous saline for 7 d. After decapitation, intrascapular brown adipose tissue (BAT), epidydimal fat (WAT), and the femoral muscle (MUS) were surgically removed and immediately frozen in liquid nitrogen, then stored at À80 C until RNA extraction.
Serum leptin concentration
Serum samples were collected after an overnight fast and immediately frozen at 20 C. Serum leptin was measured by commercially available kit (sandwich enzyme immunoassay, Immune Biological Laboratory, Gunma, Japan).
Northern blot analysis
The PCR primers were designed to the coding region of the rat UCP2, UCP3 and ob gene for the probe preparation. Total cellar RNA was prepared from various rat tissues with, the use of Isogen (Nippon gene, Toyama, Japan) according to the manufacture's protocol. All data were expressed as the mean AE s.e.m. The statistical signi®cance of difference in mean values was assessed by Student's t-test.
Results
The effects of chronic treatment with T3 on UCP family mRNAs
The results of northern blot analysis regarding UCP1 mRNA in BAT, UCP2 mRNA in WAT, and UCP3 mRNA in MUS are shown in Figure 1A . All the mRNAs expression of this UCP family was up-regulated in BAT, WAT, and MUS to more than 1.3-fold, 1.7-fold and 2.0-fold in the T3 group compared with those in the controls (P`0.05 in BAT, P`0.01, P`0.01 vs in WAT and MUS).
The effects of T3 administration on the ob mRNA in WAT and serum leptin concentration
The expression of ob gene mRNA in WAT decreased to 0.5-fold of the controls in T3-treated rats compared with that in the controls (P`0.01) ( Figure 1B) . Serum leptin level concomitantly decreased to 0.5-fold in T3 group (P`0.01) ( Figure 1B) .
Discussion
The present study demonstrated that hyperthyroid status induced by daily T3 administration increased not only UCP1 mRNA expression in BAT but also UCP2 mRNA expression in WAT, and UCP3 mRNA expression in MUS. In contrast, the same treatment with T3 decreased both ob mRNA and serum leptin level. Leptin has been shown to increase UCP2 and UCP3 mRNA in the rat. 4 However, the present ®nding that not only ob gene expression but serum leptin concentration was reduced by T3 excludes a possibility that leptin may be a mediator to up-regulate UCP2 and UCP3 under hyperthyroidism.
Fasting has been demonstrated rather to up-regulate UCPs mRNA. 5 Hyperthyroidism in the present study reduced body weight and increased UCP2 and UCP3 expression (data not shown). However, weight reduction does not necessarily re¯ect changes in UCPs mRNA expression in the heart or BAT. 5 In addition, the weight loss due to hyperthyroidism, on the contrary, increased UCPs expression, even in the heart and BAT in the present study (data not shown). These ®ndings can thus negate an assumption that the upregulated UCPs expression may be caused by the weight loss per se.
Taken together, the present study provides evidence that thyroid hormone is one of the strong activators of the UCP family, which contributed to the energy expenditure in hyperthyroidism. To this picture of UCP action, we can now add novel insights into regulation of energy expenditure. Chronic treatment with thyroid hormone T Masaki et al
